Fortress Biotech, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $85.6M | $211.9M | $150.9M |
| Jun 2017 | $99.2M | $249.8M | $144.3M |
| Sep 2017 | $123.8M | $245.1M | $110.5M |
| Dec 2017 | $125.4M | $246.0M | $95.0M |
| Mar 2018 | $157.5M | $265.1M | $124.0M |
| Jun 2018 | $140.6M | $236.9M | $98.6M |
| Sep 2018 | $140.3M | $224.9M | $95.9M |
| Dec 2018 | $121.3M | $141.0M | $65.5M |
| Mar 2019 | $149.8M | $200.5M | $116.4M |
| Jun 2019 | $137.4M | $227.3M | $149.4M |
| Sep 2019 | $146.6M | $221.6M | $134.9M |
| Dec 2019 | $153.9M | $226.4M | $136.9M |
| Mar 2020 | $153.5M | $228.8M | $135.9M |
| Jun 2020 | $151.7M | $268.6M | $183.3M |
| Sep 2020 | $119.7M | $295.9M | $218.4M |
| Dec 2020 | $136.4M | $333.4M | $233.4M |
| Mar 2021 | $146.8M | $391.0M | $289.9M |
| Jun 2021 | $169.9M | $418.2M | $275.0M |
| Sep 2021 | $195.4M | $407.8M | $252.7M |
| Dec 2021 | $170.6M | $396.5M | $305.7M |
| Mar 2022 | $214.4M | $407.9M | $287.5M |
| Jun 2022 | $216.3M | $364.0M | $248.8M |
| Sep 2022 | $222.2M | $323.6M | $208.4M |
| Dec 2022 | $244.3M | $294.3M | $178.3M |
| Mar 2023 | $243.7M | $263.6M | $152.5M |
| Jun 2023 | $196.7M | $180.7M | $78.0M |
| Sep 2023 | $163.8M | $150.5M | $72.3M |
| Dec 2023 | $165.9M | $167.5M | $80.9M |
| Mar 2024 | $168.6M | $164.6M | $83.8M |
| Jun 2024 | $160.3M | $145.7M | $76.2M |
| Sep 2024 | $139.8M | $127.1M | $58.9M |
| Dec 2024 | $145.9M | $144.2M | $57.3M |
| Mar 2025 | $145.6M | $178.1M | $91.3M |
| Jun 2025 | $122.5M | $159.9M | $74.4M |
| Sep 2025 | $116.2M | $181.4M | $86.2M |
| Dec 2025 | $123.4M | $185.5M | $79.4M |
| Mar 2026 | $154.5M | $356.9M | $255.8M |
| Jun 2026 | $110.6M | $316.7M | $196.6M |